This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Changzhou Le Sun Pharmaceuticals Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Hao Shao - Innovator in Therapeutic Compounds
Introduction
Hao Shao is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors for protein kinases. His work is crucial in addressing proliferative disorders, including cancer.
Latest Patents
Hao Shao holds a patent for therapeutic compounds that are designed to inhibit protein kinases, specifically cyclic dependent kinases (CDKs) such as CDK9. The patent describes compounds of formula (I), where R is NH or NHMe, and R is halo. The invention also includes processes for preparing these compounds, pharmaceutical compositions containing them, and their applications in treating diseases where protein kinase/CDK activity is implicated. He has 1 patent to his name.
Career Highlights
Hao Shao is associated with Changzhou Le Sun Pharmaceuticals Limited, where he continues to advance his research in therapeutic compounds. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
Hao Shao collaborates with Shudong Wang, contributing to the innovative research environment at Changzhou Le Sun Pharmaceuticals Limited.
Conclusion
Hao Shao's contributions to the field of therapeutic compounds highlight his role as an important inventor in the pharmaceutical industry. His work on protein kinase inhibitors is paving the way for new treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile